Spectinomycin
From Wikipedia, the free encyclopedia
Spectinomycin
|
|
Systematic (IUPAC) name | |
(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)- 4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino) decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one |
|
Identifiers | |
CAS number | 1695-77-8 |
ATC code | J01XX04 |
PubChem | 15541 |
DrugBank | APRD01232 |
Chemical data | |
Formula | C14H24N2O7 |
Mol. weight | 332.35 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Spectinomycin (marketed as the hydrochloride salt spectinomycin hydrochloride under the trade name Trobicin®) is an aminocyclitol antibiotic produced by the bacterium Streptomyces spectabilis. It binds to the 30S ribosomal subunit in invading bacteria and interrupts protein synthesis. It is given by injection to treat gonorrhea. Side effects include itching, chills, and red rash.